Ranbaxy gets USFDA nod for to sell muscle-relaxing tabs in US
Written by Administrator
Saturday, 17 May 2008
Ranbaxy has received the US Food and Drug Administration's (USFDA) approval for selling cyclobenzaprine hydrochloride tablets in different strengths in the US markets.
Kmart Pharmacy has launch of the American Fare Dollar Program, which offers pharmacy customers a choice of 10 over-the-counter (OTC) medications from Kmart's proprietary American Fare brand for only…
Readmore
09.09.2007 | Outsourcing
The pharmaceutical manufacturers in the United States have attacked the proposed pharma policy of India saying that it would contravene the stated goal of liberalizing the sector, and sought some…
Readmore
09.09.2007 | Homeopathy
The Homeopatic manufacturing units must fulfill the conditions stated by the government of India under 67-G
Readmore
13.05.2008 | FDA
The US Food and Drug Administration has approved a new formulation of the genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood.
Readmore
19.06.2008 | Biotechnology
According to an IMS Health study, global sales of biotech drugs increased 12.5 percent in 2007 to more than $75 billion that is twice as fast as the pharmaceutical…
Readmore
05.02.2008 | Nanotechnology
Researchers in Germany have grown ordered, vertically aligned zinc oxide nanorods that emit laser light. The laser excitation down to a spot size smaller than 1µm and found that…
Readmore
20.12.2007 | Packaging
Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and…
Readmore